Last reviewed · How we verify
NCT06548464
Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients
trial in Stomach Neoplasms in 18,000 participants. Completed in 6 August 2024.
1 August 2024
Quick facts
| Lead sponsor | Chang-Ming Huang, Prof. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 18,000 |
| Start date | 1 June 2024 |
| Primary completion | 1 August 2024 |
| Estimated completion | 6 August 2024 |
| Sites | 1 location across China |
Conditions studied
- Stomach Neoplasms — all drugs for Stomach Neoplasms →
- Gastrectomy — all drugs for Gastrectomy →
- Machine Learning — all drugs for Machine Learning →
Sponsor
Chang-Ming Huang, Prof. — full company profile →
Who can join
Eligibility, any sex, with Stomach Neoplasms or Gastrectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This multicenter, retrospective cohort study aimed to develop and validate an explainable prediction model for prognosis after gastrectomy in patients with gastric cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06548464
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stomach Neoplasms
Currently open trials in the same condition.
- NCT07482566 — Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer · NA · recruiting
- NCT06885697 — Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi · Phase 1 · recruiting
- NCT07504913 — Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41 · recruiting
- NCT07113340 — Carina™ Surgical Platform for Minimal Radical Gastrectomy · NA · active not recruiting
- NCT06630130 — Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer · Phase 2 · recruiting
Other Chang-Ming Huang, Prof. trials
Trials by the same sponsor.
- NCT06716593 — Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT · completed
- NCT06573307 — Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvan · completed
- NCT06673472 — Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with No · completed
- NCT06467591 — Prediction Model for Advanced Gastric Cancer in Elderly · completed
- NCT06663852 — ML Decision Model for G-NEC Adjuvant Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06548464 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chang-Ming Huang, Prof.
- Last refreshed: 12 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06548464.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing